Signals of Toxicity Associated With Gene Therapy: The Case of Etranacogene Dezaparvovec in the Treatment of Hemophilia B

Journal of Pharmacy Technology · Published 2026-04-03 · DOI 10.1177/87551225261433445

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1177/87551225261433445

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles